FDA Panel Gives Thumbs Up to 90-Day Glucose Monitor

Unanimous agreement that device is safe and effective. The FDA’s Clinical Chemistry and Clinical Toxicology Devices Panel voted 8-0 in three separate questions that the Eversense device appeared to be safe and effective, and that its benefits outweighed the risks

Source: FDA Panel Gives Thumbs Up to 90-Day Glucose Monitor